MDGL
Madrigal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$541.08
−0.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 83.54x
- P/E 2028E
- 23.14x
- P/S forward
- 6.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 23.87x
- Price / sales
- 9.74x
- Price / cash flow
- -63.23x
Enterprise value
- Enterprise value
- $12.0B
- EV / sales
- 9.35x
- EV / EBITDA
- -40.20x
- EV / EBIT
- -37.23x
- Market cap
- $12.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026